Melding Pharmacogenomic Effect of MDR1 and CYP3A5 Gene Polymorphism on Tacrolimus Dosing in Renal Transplant Recipients in Northern India

INTRODUCTION: Tacrolimus (TAC) is the mainstay immunosuppressant for renal transplantation. A narrow therapeutic index, multiple drug interactions, and interindividual variability in pharmacokinetics make it obligatory to monitor therapeutic drug levels. The Multidrug resistance gene 1 (MDR1) and CY...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Narayan, Jaiswal, Akhilesh, Behera, Manas Ranjan, Agarwal, Vikas, Kushwaha, Ravi, Bhadauria, Dharmendra, Kaul, Anupama, Gupta, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943758/
https://www.ncbi.nlm.nih.gov/pubmed/31922058
http://dx.doi.org/10.1016/j.ekir.2019.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943758/
https://www.ncbi.nlm.nih.gov/pubmed/31922058
http://dx.doi.org/10.1016/j.ekir.2019.09.013

Ejemplares similares